Citizens National Bank Trust Department’s AstraZeneca AZN Stock Holding History

Citizens National Bank Trust Department’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.44M	Buy	13,045 +103	+0.8%	+$19.4K	0.36%	68
2026 Q1	$2.51M	Sell	12,942 -242	-2%	-$46.7K	0.42%	61
2025 Q4	$2.42M	Sell	13,184 -289	-2%	-$50.7K	0.42%	63
2025 Q3	$2.07M	Sell	13,473 -255	-2%	-$38.6K	0.37%	73
2025 Q2	$1.92M	Buy	13,728 +181	+1%	+$25.4K	0.38%	76
2025 Q1	$1.99M	Buy	13,547 +417	+3%	+$60.3K	0.43%	66
2024 Q4	$1.72M	Buy	13,130 +297	+2%	+$41.6K	0.36%	76
2024 Q3	$2M	Sell	12,833 -12	-0.1%	-$1.94K	0.42%	68
2024 Q2	$2M	Buy	12,845 +1,617	+14%	+$243K	0.45%	63
2024 Q1	$1.52M	Buy	11,228 +2,315	+26%	+$307K	0.35%	78
2023 Q4	$1.2M	Buy	8,913 +4,945	+125%	+$643K	0.3%	86
2023 Q3	$537K	Buy	+3,968	New	+$542K	0.15%	107

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citizens National Bank Trust Department's AZN Position: Q2 2026 in Review

Citizens National Bank Trust Department increased its AstraZeneca (AZN) stake by 0.8% in Q2 2026, buying an estimated $19.4K and bringing the position to 13,045 shares worth $2.44M. The position accounts for 0.36% of the portfolio, ranked #68.

Citizens National Bank Trust Department first reported a position in AZN in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.51M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Citizens National Bank Trust Department held 13,045 shares of AstraZeneca worth $2.44M as of Q2 2026.
Citizens National Bank Trust Department bought 103 AstraZeneca shares in Q2 2026, an estimated $19.4K.
AstraZeneca made up 0.36% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #68 holding.
Citizens National Bank Trust Department first reported a position in AstraZeneca in Q3 2023 and has held it in 12 quarters since.
Citizens National Bank Trust Department's AstraZeneca position peaked at $2.51M in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.